{"id":8885,"date":"2022-11-24T13:48:00","date_gmt":"2022-11-24T12:48:00","guid":{"rendered":"https:\/\/bbmri.at\/?post_type=news-articles&#038;p=8885"},"modified":"2024-08-18T15:19:43","modified_gmt":"2024-08-18T13:19:43","slug":"regulatorische-herausforderungen-fuer-ki-basierte-diagnostika","status":"publish","type":"news-articles","link":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/","title":{"rendered":"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika"},"content":{"rendered":"    <div id=\"main_textblock_46738523becaaedb36204ea772787568\" class=\"content-row content-row-main_text\">\n        <div class=\"contentPart-main contentPart-main-main_text trans \">\n            <div class=\"contentPart_inner\">\n                \n                                    <h1 class=\"heading_main_txt HL_main\">\n                        Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostik &#8211; Weitere IVDR-\u00c4nderungen: ein Schritt in die richtige Richtung, aber &#8230;                    <\/h1>\n                \n                                    <h3 class=\"subheading_main_txt HL_sub\">\n                        Die IVDR ist in Europa bereits in Kraft getreten und wirkt sich auch auf Hersteller und Anwender von KI-basierten In-vitro-Diagnostika aus.  Kurt Zatloukal spricht auf dem 9. Kongress f\u00fcr digitale Pathologie und KI in London (Dezember 2022) \u00fcber die Auswirkungen der IVDR und die wichtigsten Entwicklungen in diesem Bereich.                    <\/h3>\n                \n                \n                            <\/div>\n\n\n\n            <div class=\"contentPart-sidebarDummy\"><\/div>\n        <\/div>\n\n    <\/div>\n\n\n    <div id=\"text_imgblock_f69c6d26671e02ab912afb004e244e12\" class=\"content-row content-row-text_img\">\r\n        <div class=\"contentPart-main contentPart-main-text_img trans \">\r\n            <div class=\"contentPart_inner\">\r\n                <div class=\"text_imgBox flex text_img_ratio\">\r\n\r\n                    <div class=\"part_text fl_top_hr\">\r\n                                                                            <div class=\"textpart text1624\">\r\n                                <p>Die IVDR-\u00dcbergangsfrist wurde k\u00fcrzlich f\u00fcr die sich bereits auf dem Markt befindlichen IVDs bis zum 26. Mai 2026 verl\u00e4ngert. Die Verl\u00e4ngerung gibt der Industrie mehr Zeit, die Anforderungen der IVDR zu erf\u00fcllen und bestehende IVD-Ger\u00e4te neu zertifizieren zu lassen. F\u00fcr alle neuen Produkte gilt die IVDR jedoch bereits jetzt in vollem Umfang. Dies gilt auch f\u00fcr KI-basierte In-vitro-Diagnostika, bei denen es sich in der Regel um Produkte der Klasse C handelt.<\/p>\n<p>Die IVDR gilt auch f\u00fcr so genannte laborentwickelte Tests oder hausinterne IVD-Tests, d. h. f\u00fcr Tests, die im diagnostischen Labor der Gesundheitseinrichtung hergestellt und angewendet werden.<\/p>\n<p>Diese regulatorischen Entwicklungen stellen Hersteller, Anwender und Aufsichtsbeh\u00f6rden vor neue Herausforderungen. Au\u00dferdem besteht weiterhin Bedarf an einem besseren Verst\u00e4ndnis, wie die IVDR-Anforderungen auf die digitale Pathologie und KI-Algorithmen angewendet werden.<\/p>\n                            <\/div>\r\n                                            <\/div>\r\n\r\n                    \r\n                        <div class=\"part_img\">\r\n                                                        <a  class=\"img_link\" >\r\n                                                                <img decoding=\"async\" src=\"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/63_2022-11_IVDR-Article-PathologyLab-KZ_BILD.JPG-550x477.jpg\" alt=\"A newspaper interview with Prof. Zatloukal\" class=\"img_text_img\">\r\n                                                                    <span class=\"img-capt\">\u00a9 European Hospital<\/span>\r\n                                                            <\/a>\r\n                        <\/div>\r\n\r\n                    \r\n                <\/div>\r\n            <\/div>\r\n            <div class=\"contentPart-sidebarDummy\"><\/div>\r\n\r\n        <\/div>\r\n    <\/div>\r\n\n\n    <div id=\"links_downloadsblock_a80f809e235bb8c75857a301d1599240\" class=\"content-row content-row-links_downloads  \">\r\n        <div class=\"contentPart-main contentPart-main-links_downloads trans \">\r\n            <div class=\"contentPart_inner contentPart_inner-links_downloads  flex_col\">\r\n                                    <div class=\"linkBox column\">\r\n                                                                                    <div class=\"links_inner\">\r\n                                    <div class=\"btnBox\">\r\n                                        <a href=\"https:\/\/www.global-engage.com\/event\/digital-pathology\/\" target=\"_blank\" class=\"btnBox_inner_link btnBox_links_inner_left flex\">\r\n                                            <span class=\"main_btn_icon main_btn_icon_links_downloads\"><\/span>\r\n                                            <span class=\"main_btn_icon_hover main_btn_icon_hover_downloads\"><\/span>\r\n                                            <span class=\"main_btn_font btnBox_inner\">Weitere Informationen werden auf dem 9. Kongress f\u00fcr digitale Pathologie und k\u00fcnstliche Intelligenz (7.-8. Dezember 2022, London, UK) und in der Pr\u00e4sentation von Kurt Zatloukal bereitgestellt<\/span>\r\n                                        <\/a>\r\n                                    <\/div>\r\n                                <\/div>\r\n                                                                        <\/div>\r\n                \r\n\r\n\r\n                            <\/div>\r\n\r\n            <div class=\"contentPart-sidebarDummy\"><\/div>\r\n\r\n        <\/div>\r\n    <\/div>\r\n","protected":false},"excerpt":{"rendered":"<p>Artikel basiert auf einem Interview mit BBMRI.at-Direktor Kurt Zatloukal auf dem 9. Digital Pathology an AI Kongress in London<\/p>\n","protected":false},"featured_media":1478,"template":"","meta":{"_acf_changed":false,"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[153,155],"class_list":["post-8885","news-articles","type-news-articles","status-publish","has-post-thumbnail","hentry","category-events-de","category-for-researchers-de-events-de"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at\" \/>\n<meta property=\"og:description\" content=\"Artikel basiert auf einem Interview mit BBMRI.at-Direktor Kurt Zatloukal auf dem 9. Digital Pathology an AI Kongress in London\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/\" \/>\n<meta property=\"og:site_name\" content=\"BBMRI.at\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-18T13:19:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/Regulatory-challenges-AI-based-diagnostics.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"609\" \/>\n\t<meta property=\"og:image:height\" content=\"457\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/\",\"url\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/\",\"name\":\"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bbmri.at\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bbmri.at\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Regulatory-challenges-AI-based-diagnostics.jpeg\",\"datePublished\":\"2022-11-24T12:48:00+00:00\",\"dateModified\":\"2024-08-18T13:19:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bbmri.at\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Regulatory-challenges-AI-based-diagnostics.jpeg\",\"contentUrl\":\"https:\\\/\\\/bbmri.at\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/Regulatory-challenges-AI-based-diagnostics.jpeg\",\"width\":609,\"height\":457},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bbmri.at\\\/de\\\/news-articles\\\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/bbmri.at\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bbmri.at\\\/#website\",\"url\":\"https:\\\/\\\/bbmri.at\\\/\",\"name\":\"BBMRI.at\",\"description\":\"Biobanking and BioMolecular resources Research Infrastructure Austria\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bbmri.at\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/","og_locale":"de_DE","og_type":"article","og_title":"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at","og_description":"Artikel basiert auf einem Interview mit BBMRI.at-Direktor Kurt Zatloukal auf dem 9. Digital Pathology an AI Kongress in London","og_url":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/","og_site_name":"BBMRI.at","article_modified_time":"2024-08-18T13:19:43+00:00","og_image":[{"width":609,"height":457,"url":"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/Regulatory-challenges-AI-based-diagnostics.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/","url":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/","name":"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika - BBMRI.at","isPartOf":{"@id":"https:\/\/bbmri.at\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/#primaryimage"},"image":{"@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/#primaryimage"},"thumbnailUrl":"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/Regulatory-challenges-AI-based-diagnostics.jpeg","datePublished":"2022-11-24T12:48:00+00:00","dateModified":"2024-08-18T13:19:43+00:00","breadcrumb":{"@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/#primaryimage","url":"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/Regulatory-challenges-AI-based-diagnostics.jpeg","contentUrl":"https:\/\/bbmri.at\/wp-content\/uploads\/2023\/05\/Regulatory-challenges-AI-based-diagnostics.jpeg","width":609,"height":457},{"@type":"BreadcrumbList","@id":"https:\/\/bbmri.at\/de\/news-articles\/regulatorische-herausforderungen-fuer-ki-basierte-diagnostika\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/bbmri.at\/de\/"},{"@type":"ListItem","position":2,"name":"Regulatorische Herausforderungen f\u00fcr KI-basierte Diagnostika"}]},{"@type":"WebSite","@id":"https:\/\/bbmri.at\/#website","url":"https:\/\/bbmri.at\/","name":"BBMRI.at","description":"Biobanking and BioMolecular resources Research Infrastructure Austria","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bbmri.at\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/news-articles\/8885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/news-articles"}],"about":[{"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/types\/news-articles"}],"version-history":[{"count":3,"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/news-articles\/8885\/revisions"}],"predecessor-version":[{"id":12417,"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/news-articles\/8885\/revisions\/12417"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/media\/1478"}],"wp:attachment":[{"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/media?parent=8885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bbmri.at\/de\/wp-json\/wp\/v2\/categories?post=8885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}